Evidence to Avoid Overtesting and Overuse in Diabetes Mellitus and Other Diseases

Am Fam Physician. 2020 Nov 15;102(10):583-584.

Authors

Kathleen Barry¹, David C Slawson², Allen F Shaughnessy³

Affiliations

¹ University of Massachusetts Medical School, Worcester, MA, USA.
² Atrium Health, Charlotte, NC, USA.
³ Tufts University School of Medicine, Boston, MA, USA.

PMID: 33179893

No abstract available

Publication types

Editorial

MeSH terms

Asymptomatic Diseases
Blood Glucose / metabolism
Blood Glucose Self-Monitoring
Clinical Decision-Making*
Diabetes Mellitus / diagnosis
Diabetes Mellitus / drug therapy*
Diabetes Mellitus / metabolism
Drug Costs
Evidence-Based Medicine
Glycated Hemoglobin / metabolism
Humans
Hypoglycemic Agents / economics
Hypoglycemic Agents / therapeutic use*
Insulins / economics
Insulins / therapeutic use*
Mass Screening
Medical Overuse / prevention & control*

Substances

Blood Glucose
Glycated Hemoglobin A
Hypoglycemic Agents
Insulins
hemoglobin A1c protein, human